Amanote Research

Amanote Research

    RegisterSign In

Pmd156 - Next Generation Sequencing: Benefit Analysis to Support a Strategic Adoption Model in the Italian NHS

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1605
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
Date

October 1, 2018

Authors
A. BaggiD. BellavistaG. BonettiM. DionisiJ.M. FranziniG. GancitanoL. MasettiP. PintoR. ScalamognaM. Volpe
Publisher

Elsevier BV


Related search

Barriers to Clinical Adoption of Next-Generation Sequencing: A Policy Delphi Panel's Solutions

Personalized Medicine
MedicineMolecular MedicinePharmacology
2017English

Next Generation Sequencing

Methods in Molecular Biology
GeneticsMolecular Biology
2018English

Next-Generation Sequencing

2016English

Pediatrics: Sequencing the Next Generation

Cell
BiochemistryGeneticsMolecular Biology
2012English

Next-Generation Sequencing to Guide Clinical Trials

Clinical Cancer Research
Cancer ResearchOncology
2015English

Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe® Panel

Frontiers in Oncology
Cancer ResearchOncology
2020English

Next Generation Sequencing in Big Data

International Journal of Trend in Scientific Research and Development
2018English

Analysis of Error Profiles in Deep Next-Generation Sequencing Data

Genome Biology
2019English

Targeted Therapy According to Next Generation Sequencing-Based Panel Sequencing

Fukushima Journal of Medical Sciences
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy